The market (SPY) has been on fire this year (+21.4%), however plenty of very attractive long-term investment opportunities remain. This week’s Weekly shares the performance of each of our holdings across all three of our strategies, and then provides concise commentary on attractive opportunities among REITs, healthcare, growth stocks and our high-income low-beta “Alternative Fixed Income” strategy. We conclude with a little advice.
All Blue Harbinger portfolios delivered double digit gains in January easily outpacing the 8% gain for the S&P 500. What’s more, this violent market snapback has been mostly predictable, but the question is whether it tripped you up (did you panic and sell at the wrong time?). This report reviews the performance of our investment strategies, including commentary on many of our individual holdings. We also highlight where we’re seeing the best opportunities going forward.
In 5 years, you’ll probably wish you bought a few shares of these attractive growth stocks. Granted, many of our readers are focused on dividend stocks; however, we believe in the importance of diversifying some of your investment dollars across a variety of investment styles, particularly when they present attractive opportunities. All of the stocks on our list have enormous long-term price appreciation potential. We’re not suggesting anyone bet the farm on growth stocks, but adding a few attractive ones to your portfolio is worth considering. Without further ado, here is the list…
This report provides an update on two attractive buying opportunities we have written about in the past. Both exhibit very important characteristics if you’re looking for significant and attractive upside price appreciation potential.
Nervous short-term profit-taking and a sympathy sell-off from Twitter CEO Jack Dorsey's testimony before Congress yesterday, combined to create some very attractive opportunities to buy a handful of powerful growth stocks, especially if you're a dip-buyer.
We just made a new purchase in our Blue Harbinger Disciplined Growth portfolio. And before you start wondering, this is NOT a high-income investment. This is a powerful long-term cash flow thesis, and the recent short-term sell-off has created a compelling entry point.